STOCK TITAN

Kenvue Inc. - $KVUE STOCK NEWS

Welcome to our dedicated page for Kenvue news (Ticker: $KVUE), a resource for investors and traders seeking the latest updates and insights on Kenvue stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Kenvue's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Kenvue's position in the market.

Rhea-AI Summary

Kenvue Inc. (NYSE: KVUE) reported first quarter 2024 results with a 1.1% increase in net sales to $3.9 billion and 1.9% organic growth. Diluted earnings per share were $0.15, adjusted to $0.28. Gross profit margin expanded to 57.6%, operating income margin was 14.1%. Initiatives were approved to reduce the global workforce by 4% with cost savings of $350 million by 2026. Outlook for 2024 includes a reported net sales growth of 1.0% to 3.0% and adjusted diluted earnings per share in the range of $1.10 - $1.20.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.24%
Tags
-
Rhea-AI Summary

Kenvue Inc. (NYSE: KVUE) has had its near-term greenhouse gas emissions reduction targets validated by the Science Based Targets initiative (SBTi), aligning with efforts to limit global temperature rise. The company commits to a 42% reduction in absolute Scope 1 and 2 GHG emissions by 2030 compared to 2020 levels. Additionally, Kenvue aims for 75% of its suppliers to have science-based targets by 2028. This validation underscores the company's dedication to combating climate change and advancing its Healthy Lives Mission, focusing on the well-being of people and the planet.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.43%
Tags
none
-
News
Rhea-AI Summary
Kenvue Inc. (NYSE: KVUE) declares a quarterly cash dividend of $0.20 per share on its common stock, payable in the second quarter of 2024. The dividend will be paid on May 22, 2024, to shareholders of record as of May 8, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.58%
Tags
dividends
Rhea-AI Summary
Kenvue Inc. (KVUE) will announce its Q1 2024 financial results on May 7, 2024. The conference call and webcast will discuss the results, accessible via phone or web. The company is a leading consumer health company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.4%
Tags
-
Rhea-AI Summary
Kenvue Inc. to showcase new data at the American Academy of Dermatology Annual Meeting, highlighting the effectiveness of Neutrogena® and Aveeno® products in improving skin health. The company's commitment to science-backed skin care is evident in their research findings and hands-on experiences at the event.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.12%
Tags
-
Rhea-AI Summary
Kenvue Inc. (NYSE: KVUE) announces CEO and CFO participation at CAGNY Conference. Thibaut Mongon and Paul Ruh to present on February 23, 2024, in Boca Raton, Florida, at 10:00 a.m. Eastern Time. Live webcast and replay details provided.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.74%
Tags
conferences
Rhea-AI Summary
Kenvue Inc. (NYSE: KVUE) reported a 3.3% increase in net sales to $15.4 billion for FY’23, with organic growth of 5.0%. However, Q4’23 saw a 2.7% decrease in net sales to $3.7 billion, with organic growth of (2.4)%. The company's full-year and fourth quarter financial results, including gross profit margin, adjusted operating income margin, interest expense, net, and taxes, were also disclosed. Kenvue expects 2024 net sales growth of 1.0% to 3.0% with organic growth in the range of 2.0% to 4.0%. Adjusted operating income margin is projected to be slightly below 2023, with adjusted diluted earnings per share expected to be in the range of $1.10 - $1.20.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.8%
Tags
-
News
Rhea-AI Summary
Kenvue Inc. (NYSE: KVUE) has declared a dividend of $0.20 per share on its common stock, payable in the first quarter of 2024. The dividend will be paid on February 28, 2024, to shareholders of record as of February 14, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.57%
Tags
dividends
-
Rhea-AI Summary
Kenvue Inc. (NYSE: KVUE) will announce its financial results for the fourth quarter and full year ending December 31, 2023, before market open on February 8, 2024. The company, the world’s largest pure-play consumer health company by revenue, will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the financial results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.15%
Tags
Rhea-AI Summary
Kenvue Inc. (KVUE) will participate in Morgan Stanley's Global Consumer & Retail Conference. CEO Thibaut Mongon and CFO Paul Ruh will have a fireside chat on December 6, 2023. The webcast will be available at https://investors.kenvue.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
Kenvue Inc.

NYSE:KVUE

KVUE Rankings

KVUE Stock Data

38.45B
1.73B
0.02%
99.17%
1.81%
Toilet Preparation Manufacturing
Manufacturing
Link
United States of America
SKILLMAN